Breast care pathway

Breast Ultrasound

From screening to diagnosis to staging to monitoring, GE Healthcare offers solutions across the entire breast care pathway including Invenia ABUS 2.0, designed to detect cancer in dense breast tissue.

Invenia ABUS 2.0
LOGIQ E10 Series
LOGIQ Fortis™

Invenia ABUS 2.0 for dense breasts

Designed for screening

Improve breast cancer detection by 35.7 percent over mammography alone.2

Remarkable image quality

Look differently at dense breast tissue with advanced interpretation tools

AI Assistant

Helps to detect and characterize breast lesions for clinical confidence

LOGIQ E10 Series Ultrasound

AI decision support

Breast Assistant powered by Koios DS™ harnesses AI for clinical confidence

Advanced breast tools

Label, measure and describe lesions, nodules, and lymph nodes

Compare assistant

Compare a prior ultrasound, mammography, CT or MR image with current images

2D shear wave elastography

Quantiative measure of tissue elasticity shown in color-coded elastograms

LOGIQ Fortis™ Ultrasound

AI decision support

Breast Assistant powered by Koios DS™ harnesses AI for clinical confidence

Auto lesion segmentation

Saves keystrokes and provides consistency when measuring lesions

Measure assistant

Simple steps to assist the user with breast measurements

Breast productivity

Measurement package to make labeling, measuring and describing lesions easy

Personalized breast care with ultrasound

REFERENCES
  1. 1. Mandelson et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000; 92:1081–1087.
  2. 2. FDA PMA P110006 summary of safety and effectiveness

Have a question? We would love to hear from you.

JB14080XX